Capillary Technologies: Business Overview & Financial Analysis

Capillary Technologies is a Bengaluru-headquartered enterprise SaaS company founded in 2012. It provides AI-powered, cloud-native loyalty and customer engagement solutions that help large enterprises manage loyalty programmes, customer data, personalised engagement, rewards and analytics. Its business is predominantly subscription-led and serves customers across the US, Europe and Asia. 

Capillary Technologies Business Model and Product Suite (Q1 FY27)

Capillary Technologies operates a recurring SaaS model built around long-term enterprise contracts. Management indicated that more than 90% of revenue is generated through long-term subscription contracts, typically spanning three, five or seven years. 

• Loyalty+: The core loyalty platform manages membership, subscriptions, points, rewards and other customer-retention programmes. Loyalty remains the company's largest product area. 
• Engage+: Provides personalised, one-to-one customer communication and contributes around 5% of revenue. 
• Insights+: Provides dashboards and analytics for loyalty use cases and is offered as an additional layer over the core platform rather than being separately monetised. 
• Rewards+: Provides reward capabilities particularly for banking and telecom customers and contributes around 5-7% of revenue. 
• aiRA: The company's AI layer provides conversational analytics, campaign creation and other AI-led marketing functions across the platform. 

The platform integrates customer information from sources such as point-of-sale systems, e-commerce, mobile applications and other digital channels, allowing enterprises to manage loyalty and engagement through a unified technology stack. 

Capillary Technologies Global Scale and Customer Base (Q1 FY27)

The addition of acquired businesses has expanded Capillary Technologies' global footprint. As of 30 June 2026, the platform was serving enterprise customers across 53 countries, with the US remaining its largest revenue market. 

• Brands: 465+ brands globally.
• Fortune 500 customers: 25.
• Consumer profiles: More than 2.7 billion on the platform.
• Geographic presence: 53 countries and 19 global offices.
• Employees: Around 750 globally, while the Q1 FY27 presentation separately reported total headcount of 761 as of 30 June 2026.
• Product uptime: 99.997% during Q1 FY27.
• Revenue geography: Around 60% from the US, 15% from Europe and 25% from Asia. 

Client concentration also improved. The top five customers contributed 34% of Q1 FY27 revenue versus 40% in Q1 FY26, while customers ranked six to ten contributed 15%. Revenue from the top five customers nevertheless increased from Rs 72.7 crore to Rs 86.7 crore. 

Capillary Technologies Q1 FY27 Financial and SaaS Performance

Capillary Technologies reported strong consolidated revenue growth in Q1 FY27, supported by organic expansion and contributions from acquired businesses. Reported PAT, however, was affected by an exceptional cyber-fraud expense. 

• Revenue from operations: Rs 256.64 crore, up 43% YoY from Rs 179.89 crore.
• Organic revenue: Rs 155.1 crore, up 17% YoY.
• Adjusted EBITDA: Rs 44.02 crore, up 132% YoY.
• Adjusted EBITDA margin: 17% versus 11% in Q1 FY26.
• Reported PAT: Loss of Rs 9.55 crore, compared with a profit of Rs 0.75 crore in Q1 FY26.
• Normalised PAT: Rs 25.44 crore, with a 10% margin after adjusting for exceptional and identified one-time items.
• ARR: Rs 1,026.6 crore, up 43% from Rs 719.6 crore in Q1 FY26.
• Organic NRR: 111%, while blended NRR stood at 113%.
• Subscription revenue: Rs 242.49 crore, up 50% YoY and accounting for 94.5% of Q1 FY27 revenue.

For context, FY26 consolidated revenue was Rs 734.60 crore, up 23% YoY, while adjusted EBITDA increased 43% to Rs 106.92 crore. The Q1 numbers therefore show a faster revenue growth rate and higher operating profitability than the FY26 full-year growth profile.

Capillary Technologies AI and Product Growth (Q1 FY27)

AI is being developed as an additional monetisation layer rather than replacing the company's core loyalty system of record. Capillary Technologies is using aiRA across analytics and action-based functions to deepen adoption within existing enterprise customers.

• aiRA adoption: Around 26 customers were live on aiRA during Q1 FY27, with fewer than 10 paying for the product at that stage.
• aiRA ARR: Management indicated an ARR of around US$2.5 million for aiRA.
• New-deal traction: Management indicated win rates of more than 35%, with AI capabilities increasingly included in large enterprise pitches.
• New ACV: Trailing 12-month new ACV, excluding one unusually large healthcare contract in the comparative period, grew 75% YoY to Rs 92.6 crore.
• Experiences+: Capillary Technologies acquired the CustomerGlu platform as a small technology-led transaction and is rebranding it as Experiences+, focused on front-end gamification and digital loyalty experiences. 

Management's product strategy is to extend the platform from a loyalty system of record into AI-led intelligence and action layers, while using additional products to increase revenue from the existing customer base. 

Capillary Technologies Acquisitions and Integration (Q1 FY27)

Acquisitions remain an important part of Capillary Technologies' growth strategy. The company has been acquiring customer portfolios and technology platforms and subsequently migrating customers onto its own technology stack to improve economics. 

• SessionM: The acquisition was completed on 1 May 2026 and added customer contracts tracking towards US$32 million of ARR.
• SessionM consideration: Net cash purchase consideration after debt-like adjustments was Rs 16.91 crore.
• Early cash generation: Management said SessionM generated around Rs 5-6 crore of free cash during its first two months under Capillary Technologies and had become profitable.
• Existing migrations: Almost all customers acquired through Persuade, Brierley and Rewards+ had migrated to the Capillary platform, with only two customers remaining.
• Kognitiv and SessionM: AI-assisted migration tools are being used to shorten migration timelines for customers acquired through these transactions.

The investment case around acquisitions therefore depends not only on acquired revenue but also on customer retention, migration execution, infrastructure optimisation and subsequent cross-selling of Capillary Technologies' products. 

Capillary Technologies Exceptional Item and Capital Allocation (Q1 FY27)

Q1 FY27 reported profitability was affected by a cyber-fraud incident at the SessionM Czech Republic subsidiary. Separately, Capillary Technologies continued deploying the fresh capital raised through its FY26 IPO. 

• Cyber-fraud provision: Rs 33.39 crore was recognised as an exceptional expense following unauthorised remittances caused by a social-engineering fraud.
• Recovery action: Around Rs 4.70 crore in beneficiary accounts had been frozen as part of recovery proceedings when the Q1 presentation was issued.
• Investigation: KPMG's forensic team was appointed for an independent investigation, while an insurance claim was also initiated.
• IPO net proceeds: Capillary Technologies received Rs 322.91 crore of net fresh-issue proceeds after its share of IPO expenses.
• Utilisation: Rs 119.69 crore had been utilised by 30 June 2026, leaving Rs 203.22 crore unutilised.
• Planned deployment: IPO proceeds are earmarked for cloud infrastructure, product and platform R&D, computer systems, inorganic growth and general corporate purposes.

Recovery from the fraud and deployment of the remaining IPO proceeds are therefore additional items to monitor alongside operating performance and acquisition integration.

Capillary Technologies Management Commentary and FY27 Outlook

Management retained the company's FY27 operating framework after Q1 and indicated that organic growth, customer expansion, acquisition synergies and AI adoption remain the main growth drivers. 

• FY27 revenue guidance: Rs 1,065 crore.
• FY27 adjusted EBITDA guidance: Rs 172 crore.
• Management stance: Management said it expects to exceed both figures but did not formally revise guidance after Q1.
• NRR growth: Existing-customer expansion is expected to come from higher platform usage, pricing increases, product upselling and expansion into additional brands, geographies and business units.
• Acquisition focus: Customer migration and cost optimisation across Kognitiv and SessionM remain key profitability levers.
• AI monetisation: Management indicated an ambition for aiRA to contribute around 5-10% of revenue during FY27, subject to enterprise adoption and budgeting cycles.

The main operating indicators to track are ARR growth, organic NRR, subscription revenue mix, adjusted EBITDA margin, migration progress and the pace at which AI products begin contributing materially to revenue.

Want to filter out stocks based on your own investment criteria? You can use the Stock Screener on Finology Ticker to evaluate stocks based on customised valuation and profitability parameters.

Sources & References

• Capillary Technologies FY26 Integrated Annual Report
• Capillary Technologies Q1 FY27 Investor Presentation
• Capillary Technologies Q1 FY27 Earnings Call Transcript
• Capillary Technologies Q1 FY27 Unaudited Financial Results and Limited Review Report
• Finology Ticker – Capillary Technologies Company Page

Disclaimer
The information presented above on Capillary Technologies has been compiled from the company's Annual Reports, Investor Presentations, Earnings Call (Concall) Transcripts, official regulatory filings and the financial data available on Finology Ticker. Certain figures, classifications or comparisons may vary due to differences in accounting policies, reporting methodologies or subsequent restatements by the company. This content is intended solely for informational purposes and should not be considered as investment advice. Investors are advised to refer to the latest company filings and the updated financial data, ratios and disclosures available on this Finology Ticker Capillary Technologies page before making any investment decision. Investment in securities market are subject to market risks. Read all the related documents carefully before investing.